Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease.

Cimini FA, Barchetta I, Carotti S, Morini S, Cavallo MG.

World J Gastrointest Pathophysiol. 2019 Sep 10;10(2):11-16. doi: 10.4291/wjgp.v10.i2.11.

2.

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.

Barchetta I, Enhörning S, Cimini FA, Capoccia D, Chiappetta C, Di Cristofano C, Silecchia G, Leonetti F, Melander O, Cavallo MG.

BMC Med. 2019 Apr 30;17(1):85. doi: 10.1186/s12916-019-1319-4.

3.

Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.

Cimini FA, Arena A, Barchetta I, Tramutola A, Ceccarelli V, Lanzillotta C, Fontana M, Bertoccini L, Leonetti F, Capoccia D, Silecchia G, Di Cristofano C, Chiappetta C, Di Domenico F, Baroni MG, Perluigi M, Cavallo MG, Barone E.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1490-1501. doi: 10.1016/j.bbadis.2019.02.021. Epub 2019 Feb 28.

PMID:
30826467
4.

Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation.

Cimini FA, D'Eliseo D, Barchetta I, Bertoccini L, Velotti F, Cavallo MG.

Cytokine. 2019 Mar;115:104-108. doi: 10.1016/j.cyto.2018.11.019. Epub 2018 Nov 22.

PMID:
30473178
5.

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.

Barchetta I, Cimini FA, Capoccia D, Bertoccini L, Ceccarelli V, Chiappetta C, Leonetti F, Di Cristofano C, Silecchia G, Orho-Melander M, Melander O, Cavallo MG.

Nutrients. 2018 Apr 23;10(4). pii: E526. doi: 10.3390/nu10040526.

6.

Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.

Barchetta I, Cimini FA, Leonetti F, Capoccia D, Di Cristofano C, Silecchia G, Orho-Melander M, Melander O, Cavallo MG.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2253-2260. doi: 10.1210/jc.2017-02751.

PMID:
29590379
7.

WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes.

Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, Di Martino M, Bertoccini L, De Bernardinis M, Leonetti F, Baroni MG, Lenzi A, Cavallo MG.

J Endocr Soc. 2017 Apr 18;1(6):660-670. doi: 10.1210/js.2017-00108. eCollection 2017 Jun 1.

8.

The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.

Bertoccini L, Sentinelli F, Incani M, Bailetti D, Cimini FA, Barchetta I, Cavallo MG, Cossu E, Lenzi A, Loche S, Baroni MG.

Lipids Health Dis. 2017 Sep 19;16(1):179. doi: 10.1186/s12944-017-0569-4.

9.

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.

Barchetta I, Cimini FA, Cavallo MG.

Nutrients. 2017 Sep 14;9(9). pii: E1015. doi: 10.3390/nu9091015. Review.

10.

Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.

Barchetta I, Angelico F, Del Ben M, Di Martino M, Cimini FA, Bertoccini L, Polimeni L, Catalano C, Fraioli A, Del Vescovo R, Morini S, Baroni MG, Cavallo MG.

Clin Sci (Lond). 2016 Oct 1;130(19):1753-62. doi: 10.1042/CS20160348. Epub 2016 Jul 25.

PMID:
27458255
11.

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, Saulle R, Perri L, Morini S, Tiberti C, Bertoccini L, Cimini FA, Panimolle F, Catalano C, Baroni MG, Cavallo MG.

BMC Med. 2016 Jun 29;14:92. doi: 10.1186/s12916-016-0638-y.

Supplemental Content

Loading ...
Support Center